Our Data

Fully integrated, prescriber-level insights that reveal where your brand, and your competitors, win or lose access.

Dashboards and Analytics

Forsyth’s interactive dashboards and analytics turn data into actionable insights. Designed for speed and usability, our dashboards help your teams:

Track patient and prescriber access trends.
Identify market opportunities and challenges.
Benchmark performance against therapeutic class or competitor activity.

Built on integrated pharmacy, medical, and prior authorization data, Forsyth dashboards provide a clear, prescriber‑level view of where access breaks down and where opportunity exists. Near real‑time updates ensure teams are working from the most current information, enabling faster prioritization and more informed decisions across brand, market access, and field teams. With intuitive visualizations and flexible views, Forsyth makes it easy to move from insight to action — without getting lost in complexity.

Data that Quantifies Prescriber Intent

To help quantify prescriber intent, Forsyth’s RxPA Data Metrics measure the following:

Attempted prior authorizations (PAs)
PA decisions (approvals/denials/appeals)
Detailed Denial Reasons (i.e., step therapy, clinical criteria not met)
Post-Approval PA insights (i.e., went on brand, reversed at pharmacy, filled alternate brand)
Competitor RxPA insights (same insights available as your own brand)

Based on these metrics, our RxPA Data enables:

Identifying Prescriber Practice Patterns (measured by intent, not just adoption)
Sales: Identify prescribers prescribing for the wrong patients targets to educate
Brand: Quantify the impact of campaigns on prescribers' brand interest
Market Access: Use data to better qualify formulary negotiation strategies
Field Reimbursement: Target in real time the access barriers impacting pull-through

RxPA Data Application: Product Life Cycle

Within the product life cycle, there are pre-launch, early launch, established market, and new competitor stages.

In the pre-launch stage, we consider competitors with high or low denial rates and develop a negotiation strategy for appropriate formulary status, to help provide an “easy button” for access.
In the early launch stage, we gain visibility into prescribing intent for your brand before a claim exists and learn from offices with successful practice patterns to quickly support those who are struggling. Early adopters who routinely get denied in the first 3 months are more likely to stop prescribing your brand. Knowing who they are quickly is pivotal, as claims won't disclose whether they are struggling to get access.
Once the market is established, we identify why prescribers are denied for your brand and competitors. This allows you to determine if you can capitalize on their areas of weakness and if your current prescribers are struggling with appropriate patient targeting or the PA administrative process.
With regards to new competitors or new competitor indications, we quickly assess where your market share might be at risk, as PA attempts are the lead indicator that there is intent for a brand and can signal future shifts in market share.

Contact Us

Our adaptive, evolutionary services are now available. Let’s partner to improve outcomes.